DB3, LLC (FKA THE DASCHLE GROUP)

Lobbying for BAVARIAN NORDIC INC. · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · North Carolina · House · Senate · $30,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Medical countermeasure development, stockpiling, and funding; issues related to vaccine cost-sharing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.